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ABSTRACT
Chlamydia trachomatis is an obligate intracellular
pathogenic bacterium that has been refractory to
genetic manipulations. Although the genomes of
several strains have been sequenced, very little
information is available on the gene structure of
these bacteria. We used deep sequencing to
define the transcriptome of purified elementary
bodies (EB) and reticulate bodies (RB) of
C. trachomatis L2b, respectively. Using an RNA-
seq approach, we have mapped 363 transcriptional
start sites (TSS) of annotated genes. Semi-
quantitative analysis of mapped cDNA reads
revealed differences in the RNA levels of 84 genes
isolated from EB and RB, respectively. We have
identified and in part confirmed 42 genome- and 1
plasmid-derived novel non-coding RNAs. The
genome encoded non-coding RNA, ctrR0332 was
one of the most abundantly and differentially
expressed RNA in EB and RB, implying an important
role in the developmental cycle of C. trachomatis.
The detailed map of TSS in a thus far unprecedented
resolution as a complement to the genome
sequence will help to understand the organization,
control and function of genes of this important
pathogen.
INTRODUCTION
Chlamydia trachomatis is the major cause of bacterial
sexually transmitted diseases and ocular infections
leading to blindness with hundreds of millions of new
cases per year (1). The outcome of infection correlates
with certain serovars: Serovars A–C invade mucosal
epithelia in the ocular tissue which can lead to
trachoma. Serovars D–K infect the urogenital tract
causing sexually transmitted diseases. The LGV serovars
L1, L2 and L3 invade lymph nodes causing the sexually
transmitted systemic syndrome LGV (lymphogranuloma
venereum). Chlamydiae are obligate intracellular gram-
negative bacteria with an innate biphasic developmental
cycle (2). The infection starts with the phagocytosis of the
metabolically inactive elementary bodies (EB) by the
eukaryotic cell (3). EB diﬀerentiate to metabolically active
reticulate bodies (RB) which replicate in a vacuole inside
the host cell. RB re-diﬀerentiate to EB, which are then
released from the cells to initiate a new cycle of infection.
Since genetic tools to manipulate the genome and
methods to culture the bacteria outside the host cell are
lacking, genome sequence analysis has been the main
approach to get insight into the biology of all
Chlamydiales. The genomes of representatives of all
biovariants of C. trachomatis have been sequenced (4–6)
and subsequent genome comparison has unveiled impor-
tant information on their evolution. The genomes of the
representatives of all four serovars show an extremely high
degree of conservation. They are similar in size
( 1.04Mbp) with variations of only 5000bp. Moreover,
846 coding sequences (CDS) out of the 889–920 CDS are
common to all serovars (5). Chlamydial genomes exhibit a
very high coding density of 90% indicating a highly
optimized usage of the coding capacity of their genomes.
However, CDSs were identiﬁed by computational analysis
and some if not most of the diﬀerences in the CDSs of the
genomes are due to the use of diﬀerent gene prediction
algorithms rather than the real gene content (5). Only
recently, transcriptome studies using microarrays (7) and
reverse transcription PCR (8) have permitted a ﬁrst eval-
uation of gene expression patterns in Chlamydia. As these
studies were based on the predicted CDSs, the real
chlamydial transcriptome has not been determined yet.
As a consequence of the high coding density, intergenic
regions (IGRs) are rare and small in C. trachomatis. This
is noteworthy since the IGRs of other bacterial genomes
often harbor the genes of small regulatory RNAs (sRNAs)
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mainly by computational predictions combined with
experimental veriﬁcation (10–12). Other approaches suc-
cessfully identiﬁed new sRNAs by way of cDNA cloning
of small-sized RNA species (14,15), and detection on tiling
arrays (16–19). Yet another method has been the
co-precipitation of sRNAs with Hfq, a conserved
sRNA-binding protein in bacteria (20), and the subse-
quent identiﬁcation of Hfq-associated transcripts on
whole genome microarrays (21) or by deep sequencing
of cDNA (22) [a.k.a. RNA-seq (23)]. Although an Hfq
homolog has not been known in Chlamydia, several
sRNA have been predicted; however, one sRNA has
been experimentally validated and studied (24,25). The
sRNA IhtA is involved in the translational regulation of
histone-like protein Hc-1.
Recently, the study of Vibrio cholera, Bacillus anthracis
and Burkholderia cenocepacia has demonstrated the feasi-
bility of the unbiased identiﬁcation of sRNAs by deep
sequencing approaches (26–28). Here we have analysed
the primary transcriptome of C. trachomatis L2b/UCH-
1/proctitis by selectively sequencing cDNA libraries
enriched for primary transcripts. Besides new open
reading frames (ORFs) that were missed in previous
genome annotation, we identiﬁed and validated several
sRNAs. The most abundant RNA discovered here seems
speciﬁc for C. trachomatis spp. Another abundant sRNA
is encoded on the pathogenicity-associated cryptic
plasmid. Our data demonstrate the power of RNA-seq
for direct RNA identiﬁcation and the discovery of the
structure and control of genes in genetically inaccessible
organisms such as obligate intracellular bacteria.
MATERIALS AND METHODS
Infection and isolation of bacterial RNA
HeLa229 (ATCC CL-2.1) cells were cultured in DMEM
(Invitrogen) containing 10% FBS (Biochrom) and
infected with C. trachomatis strain L2b with a MOI of
5 for 24h. C. trachomatis containing cells were collected
and disrupted with glass beads. Chlamydia were isolated
by diﬀerential centrifugation followed by density gradient
centrifugation as described before (29) with several
modiﬁcations to achieve better separation of EB and
RB. Cell debris was pelleted at 1500 rcf for 10min at
4 C followed by centrifugation of the Chlamydia contain-
ing supernatant at 30000 rcf for 30min. The bacterial
pellet was washed twice in sucrose-phosphate-glutamate
(SPG) buﬀer (250mM sucrose, 3.8mM KH2PO4,
7.2mM K2HPO4, 0.5mM L-glutamate, pH 7.4) and
resuspended in 2ml SPG using a 26G syringe needle.
The C. trachomatis suspension was layered on top of a
Percoll Plus (GE Healthcare) solution containing 0.25M
sucrose. EB and RB were separated based on their diﬀer-
ent buoyant densities on an in situ forming continuous
density gradient by centrifugation at 30000 rcf for
30min in a ﬁxed angle rotor. Two distinct bands were
visible containing EB (lower) and RB (upper). These
were collected and washed twice in SPG buﬀer. Purity of
EB and RB preparations was veriﬁed by electron
microscopy (Supplementary Figure S5). Pelleted bacteria
were resuspended in Trizol (Invitrogen), mechanically dis-
rupted in a homogenizer (FastPrep, MP Biomedicals) and
RNA was isolated according to the manufacturers
protocol. Contaminating DNA was digested by DNAseI
(Fermentas) and absence of DNA was controlled by PCR.
RNA quality was determined on a Bioanalyzer (Agilent).
Absence of 18S and 28S ribosomal RNA peaks supported
the purity of the bacteria preparation.
Preparation of cDNA and sequencing
cDNA cloning and pyrosequencing was performed as
described before (30) but omitting size fractionation of
RNA prior to cDNA synthesis. Equal amounts of total
RNA were used for the generation of all cDNA libraries.
Primary transcripts of total RNA were enriched by selec-
tive degradation of RNAs containing 50 mono-phosphate
(50P) by treatment with a 50 P-dependent exonuclease as it
will be described in full detail in the context of a compre-
hensive primary transcriptome study of Helicobacter
pylori (Sharma et al., submitted). Primary bacterial
transcripts (most mRNAs and sRNAs) are protected
from exonucleolytic degradation by their tri-phosphate
(50PPP) RNA ends. For linker ligation RNA was treated
with tobacco acid pyrophosphatase to generate 50-mono-
phosphates. After addition of speciﬁc 50-linkers with
unique tags for each library and poly-A-tailing, the
RNA was converted into a cDNA library. Four cDNA
libraries were generated in total: total RNA and total
RNA enriched for primary transcripts from EB and RB,
respectively. The libraries were then sequenced on a
Roche/454 GS-FLX system using the ‘Amplicon A’ and
the ‘SR70 sequencing kits’.
Analysis of sequences and statistics
After clipping of 50-linker and poly-A-tails all sequences
longer than 17 nucleotides (nt) were considered
for BLAST search. The sequences were aligned to the
C. trachomatis L2b/UCH-1/proctitis genome and
plasmid (NC_010280 and NC_010285) using WU-
BLAST 2.0. For visualization of BLAST hit locations
graph ﬁles were calculated and loaded into the
Integrated Genome Browser (Aﬀymetrix) as previously
described (31). For comparative quantiﬁcation of gene
expression, sequence numbers were counted for every
ORF including the 50-UTR if a distinct TSS was present.
Transcripts with at least 20 sequences detected in total
were considered for expression analysis. Individual
sequence numbers were normalized to the total number
of mRNA sequences per library. The threshold for a clas-
siﬁcation as diﬀerentially expressed was 2-fold.
Northern blot analysis of sRNAs
To conﬁrm the expression and size of putative transcripts
total RNA from Chlamydia was separated on a dena-
turing 10–15% polyacrylamide gel containing 8M urea
and then transferred to a nylon membrane followed by
covalent cross-linking by UV irradiation. 24-mer DNA
oligonucleotides antisense to the putative bacterial
RNAs were end labeled with (g
32P)-ATP, hybridized at
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and washed with washing buﬀer (2  SSC, 0.1% SDS).
Blots were exposed to phosphor storage screens
(Fujiﬁlm) which were then scanned by Typhoon 9200
imager (GE Healthcare).
RESULTS
Sequencing of C. trachomatis total RNA
In order to obtain a comprehensive image of the total
transcriptome of C. trachomatis, we analysed cDNA
libraries of total RNA by deep sequencing analysis. To
allow detection and quantiﬁcation of transcripts which
diﬀer between EB and RB, these developmentally
distinct forms of C. trachomatis were puriﬁed, RNA was
isolated and EB and RB cDNA libraries were generated.
To identify primary transcriptional start sites, we
sequenced two libraries for each growth form: one
generated from the original, untreated total RNA, and
the other following enrichment of primary transcripts by
selective enzymatic degradation of processed RNA species
(see ‘Materials and methods’ section for details). The
resulting four diﬀerent libraries, derived from total RNA
and RNA enriched for primary transcripts of EB and RB,
were then subjected to deep sequencing to achieve a semi-
quantitative comparison of gene expression. In total, we
analyzed 338678 sequences of the four cDNA libraries.
After removal of 50-linkers and poly-A tail sequences,
only reads longer than 17 nt (309695 reads; 91.44%)
were considered for further analysis. Clipped read
lengths up to 120 nt with 67.9% longer than 60nt were
obtained with similar read length distribution in all
libraries (Figure 1A). We then used the WU-Blast
(http://blast.wustl.edu/) algorithm to map 263949
sequences to either the C. trachomatis genome
(NC_010280, 94.5% of sequence reads) or the
C. trachomatis cryptic plasmid (NC_010285, 5.5% of
sequence reads). Sequencing read numbers per library
ranged from 73784 to 98753 and were sorted by classes
of RNA as shown in Figure 1B. Plasmid reads represented
8.4% of the RB and 0.9% of the EB libraries, respectively.
The fraction of mRNA reads was reduced by the enrich-
ment for primary transcripts since processing and degra-
dation products were removed by the enzymatic
enrichment procedure. The RB libraries contained a
large fraction of sequences which were neither found on
the chlamydial genome nor on the plasmid. Further
analyses unveiled, that these sequences were derived
from contaminating human host cell mitochondria
which apparently co-puriﬁed with RB during gradient
puriﬁcation.
Annotation of transcription start sites
The above mentioned treatment of RNA enriches for
sequence reads whose 50-end is a transcriptional start
site. To globally map the TSS of the C. trachomatis
transcriptome, mapped reads along the whole genome
were visualized by calculation of graph ﬁles displayed by
the Integrated Genome Browser (IGB). TSS were
manually annotated by inspection of sequenced regions
upstream of Open reading frames (ORFs). Sequencing
reads starting at exactly the same nucleotide position
deﬁned the TSS. This precise mapping of the TSS
unveiled a broad variation in the length of the
50-untranslated regions (UTRs) with a peak at 21–40 nt
and a number of 50-UTRs ranging over 100 nt in length
(shown in Supplementary Figure S1). Three transcripts
belong to the group of leaderless mRNAs since the TSS
equals the translation start (CTLon_464, 600, 684) (32).
Further investigation and probably re-annotation is
needed for ﬁve transcripts where the TSS is located down-
stream of the annotated translation start (CTLon_0311,
0537, 0742, 0755, 0757). These genes contain an alterna-
tive ORF downstream of the TSS which is supported by a
putative ribosome binding site. For several genes two
distinct TSS could be identiﬁed which indicates a diﬀeren-
tial regulation of gene expression by variation in 50 UTR
length. In total, sequence reads could be detected for 548
out of 934 annotated genes (58.7%). Thereof TSS could be
identiﬁed for 356 (65.0%) annotated genes located on the
bacterial chromosome comprising 317 putative protein
coding genes and 39 tRNA and rRNA genes (for details
see Supplementary Table S1). For the remaining expressed
genes, TSS could not be speciﬁed since RNAs were not
abundant enough to be identiﬁed or expressed as an
operon-like transcript. Furthermore, we could identify
16 distinct TSS in intergenic regions which lack an ORF
and therefore indicate non-coding transcripts. In addition,
we identiﬁed 25 TSS representing small non-coding
transcripts that are either partially or completely antisense
to annotated ORFs (Supplementary Table S2). Furthermore,
we detected nine long overlapping antisense transcripts, most
of them representing extended 30 UTRs (Figure S4).
Diﬀerences in the EB and RB transcriptome
The C. trachomatis L2b/UCH-1/proctitis annotation
contains 874 putative ORFs. A comparison of relative
read numbers of a given RNA between EB and RB
indicated a set of diﬀerentially expressed genes in the
two chlamydial developmental cycle stages (shown in
Tables 1 and Supplementary Table S2). The separate
sequencing of EB and RB transcripts revealed 38 genes
which are more abundant in EB and could be crucial for
host cell invasion and infectivity. This subset includes 18
hypothetical proteins of unknown function. The 46 genes
which were found to be upregulated in RB include outer
membrane proteins and genes involved in bacterial
division. Twelve genes are of unknown function.
Besides this set of overlapping genes, we also identiﬁed
deviations from previous predictions (Table 1). One inter-
esting example was the most abundant transcript account-
ing for 20% and 78% of all putative mRNA sequence
reads in the RB and EB libraries, respectively. Further
analysis of this transcript revealed its localization inside
a previously annotated ORF CTLon_0332 (homolog to
CT081). The RNA was 97nt shorter than predicted for
the annotated ORF and started at the  19 position from
the annotated translation start (Supplementary Figure S2).
The sequencing proﬁle indicated processing from a larger
transcript rather than a deﬁned TSS. Northern blot analysis
870 Nucleic Acids Research, 2010,Vol. 38,No. 3revealed two highly abundant RNA species of  80 and
240nt in size (Figure 2, ctrR0332) which ﬁts very well to
the 89 and 242 nt calculated from the sequencing data.
The major RNA molecule does not contain an ORF.
This data suggest that these transcripts encode regulatory
RNAs rather than peptides.
Although our RNA sequencing data argued against the
existence of ORFs in these RNAs, we screened proteome
databases performed with C. trachomatis for the presence
of protein sequences possibly translated from the region
covering these RNAs (33,34). No such proteins could be
identiﬁed supporting the prediction of a non-coding RNA
encoded in region 416302–416543.
We next performed BLAST searches for similar
sequences in other bacteria. Sequences with signiﬁcant
homology were only present in all sequenced
C. trachomatis strains (99–100%) and in C. muridarium
Nigg (89%), a Chlamydia species isolated from mice
with an average similarity of 90% to C. trachomatis
orthologous genes (35). These data suggest in summary,
that CTLon_0332 represents a highly abundant non-
coding RNA speciﬁc for human and mouse C. trachomatis
isolates. We have therefore renamed ORF CTLon_0332 to
ctrR0332 for C. trachomatis ncRNA0332.
Identiﬁcation of small RNAs in intergenic regions or
antisense to ORFs
Besides reads mapping to the annotated region of the
genome we also found a number of transcripts in
intergenic regions and transcripts partially or completely
antisense to annotated ORFs. Based on manual inspection
for such transcripts with a deﬁned primary transcription
start site, 16 putative small RNAs located in intergenic
regions as well as 25 small antisense RNAs could
be detected from the sequencing data. In addition,
one abundant processed RNA derived from a tRNA
containing precursor could be identiﬁed (ctrR1,
Figure 2). The sRNA candidates included ihtA, the only
previously identiﬁed chlamydial sRNA (25).
To test whether these transcripts reﬂected small RNAs,
total RNA from an EB-RB-mixture was analysed by
northern blot hybridisation. Expression of 9 out of 12
tested sRNAs was successfully validated by northern
blot analysis (Figure 2A), arguing for the presence of
multiple sRNAs in C. trachomatis. Figure 2B shows the
genomic location of these novel sRNAs. Six sRNAs
(ctrR1–3, 5–7) are located in intergenic regions. ctrR4
encodes two sRNAs and the larger transcript overlaps
the antisense located gene 403 and ctrR8 is located
antisense to gene 807. As shown in Supplementary
Figure S3 most of these sRNAs show a stable secondary
structure when analyzed by the RNAfold algorithm
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).
An in silico search for putative targets regulated by the
novel sRNAs was performed using the TargetRNA algo-
rithm (36). The results were ﬁltered for sRNA:target
interactions incorporating the translation start codon or
a putative ribosome binding site. Candidate targets are
listed in Table 2 in the order of their binding score,
starting with the highest. Most targets have at least a
7 to 9nt seed sequence. None of the newly identiﬁed
sRNA is conserved within diﬀerent species other than
Chlamydiae. However, some motifs of ctrR2, -3, -6, -8
and the plasmid encoded sRNA pL2-sRNA1 are
conserved among other species. Targets which are
putatively bound by these are underlined in Table 2.
The chlamydial cryptic plasmid encodes a highly
abundant sRNA
Virtually all isolates of C. trachomatis harbour a cryptic
plasmid of 7.5Kb (37). A total of 14459 cDNAs mapped
to the chlamydial cryptic plasmid which has a size of
Figure 1. Characterization of the cDNA libraries. (A) Length distribution of reads after 50 end-linker and polyA-tail clipping of four sequenced
C. trachomatis cDNA libraries generated from either total RNA or total RNA enriched for primary transcripts of reticulate bodies (RB) or
elementary bodies (EB), respectively. Shown are relative numbers of groups of sequence length in relation to the total number of reads per
library. (B) Sequence read distribution of the four cDNA libraries grouped into diﬀerent classes of RNAs. Transcripts antisense to ribosomal
RNAs, transfer RNAs and messenger RNAs are not shown since they represent <1% of total sequences. Transcripts located in intergenic regions
(IGR) can either be sRNA candidates, part of 50-o r3 0-UTRs of mRNAs or unannotated coding genes. The majority of the fraction of reads that
could not be mapped to the chlamydial genome corresponds to contaminating host cell RNA, mainly mitochondrial RNAs.
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Gene Description Gene no. Homolog Microarray (8)
Elementary bodies
Pseudogen CTLon_0548 CT300 –
Hypothetical protein CTLon_0186 CT814.1 Late
Hypothetical protein CTLon_0332 CT081 Late
scc2 Type III secretion chaperone (low calcium response protein H) CTLon_0833 CT576 Late
copD Putative type III secretion system protein CTLon_0836 CT579 Late
Hypothetical protein CTLon_0250 CT875 Late
Hypothetical protein CTLon_0333 CT082 Late
omcA Cysteine-rich outer membrane protein CTLon_0699 CT444 Late
Hypothetical protein CTLon_0880 CT622 Late
Hypothetical protein CTLon_0834 CT577 Late
Hypothetical protein CTLon_0242 CT867 –
Hypothetical protein CTLon_0185 CT814 Late
crpA Cysteine-rich membrane protein CTLon_0697 CT442 Late
Putative integral membrane protein CTLon_0398 CT147 Very late
Putative lipoprotein CTLon_0700 CT444.1 –
Hypothetical protein CTLon_0428 CT181 Late
ltuB Late transcription unit B protein CTLon_0331 CT080 Late
copB Putative type III secretion system membrane protein CTLon_0835 CT578 Late
Hypothetical protein CTLon_0609 CT357 –
Hypothetical protein CTLon_0255 CT005 Late
Putative protein ligase CTLon_0285 CT035 Very late
Hypothetical protein CTLon_0608 CT356 Late
omcB 60kDa cysteine-rich outer membrane protein CTLon_0698 CT443 Late
1-Acyl-sn-glycerol-3-phosphate acyltransferase CTLon_0144 CT775 Late
Putative integral membrane protein CTLon_0617 CT365 Late
ltuA Late transcription unit A protein CTLon_0629 CT377 Midlate I
Hypothetical protein CTLon_0461 CT214 Late
Putative oxidoreductase CTLon_0627 CT375 Late
Hypothetical protein CTLon_0240 CT865 –
ABC transporter, ATP-binding protein CTLon_0427 CT180 –
Hypothetical protein CTLon_0334 CT083 Late
mdhC Malate dehydrogenase CTLon_0628 CT376 Midlate I
Pseudogen CTLon_0610 CT358 –
Hypothetical protein CTLon_0536 CT288 Late
aas Long chain fatty acid-[acyl-carrier-protein] ligase CTLon_0145 CT776 Late
Hypothetical protein CTLon_0477 CT229 –
Hypothetical protein CTLon_0028 CT659 Late
rpiA Ribose-5-phosphate isomerase A CTLon_0460 CT213 Late
Reticulate bodies
pmpC Polymorphic outer membrane protein CTLon_0667 CT414 Midlate I
nrdA Ribonucleotide-diphosphate reductase subunit alpha CTLon_0199 CT827 Midlate I
Hypothetical protein CTLon_0267 CT017 Late
Hypothetical protein CTLon_0859 CT602 –
cydA Cytochrome d ubiquinol oxidase subunit I CTLon_0263 CT013 Midlate I
Putative type III secretion system chaperone CTLon_0294 CT043 Midlate I
Putative cation eﬄux protein CTLon_0678 CT423 –
Type III secretion structural protein (outer membrane ring) CTLon_0043 CT674 Midlate I
sctJ Type III secretion system protein, membrane component CTLon_0816 CT559 Midlate I
Hypothetical protein CTLon_0251 CT001 Late
tal Transaldolase B CTLon_0561 CT313 Midlate I
ftsH Cell division protein CTLon_0213 CT841 Late
ompA Major outer membrane protein CTLon_0050 CT681 Midlate II
pkn5 Putative serine/threonine-protein kinase (TTSS eﬀector protein) CTLon_0042 CT673 –
ruvB Holliday junction DNA helicase B CTLon_0291 CT040 –
Putative lipoprotein CTLon_0501 CT253 –
ihfA Integration host factor alpha-subunit CTLon_0515 CT267 Midlate I
Putative helicase CTLon_0077 CT708 Midlate I
pmpF Polymorphic outer membrane protein CTLon_0245 CT870 Midlate I
Hypothetical protein CTLon_0624 CT372 Midlate I
Hypothetical protein CTLon_0152 CT783 Midlate II
Tyrosine-speciﬁc transport protein CTLon_0190 CT818 –
clpC ATP-dependent Clp protease CTLon_0534 CT286 Midlate II
Hypothetical protein CTLon_0537 CT289 Midlate I
copN Low calcium response protein E (TTSS eﬀector protein) CTLon_0340 CT089 Midlate I
pmpG Polymorphic outer membrane protein CTLon_0246 CT871 Midlate I
uhpC Putative sugar phosphate permease CTLon_0801 CT544 Midlate I
pmpH Polymorphic outer membrane protein CTLon_0247 CT872 Midlate I
rplM 50S ribosomal protein L13 CTLon_0376 CT125 –
Hypothetical protein CTLon_0876 CT618 Midlate I
pmpE Polymorphic outer membrane protein CTLon_0244 CT869 Late
Hypothetical protein CTLon_0572 CT324 –
dppD ABC transport protein, ATPase component CTLon_0059 CT690 –
pmpB Polymorphic outer membrane protein CTLon_0666 CT413 Midlate I
Hypothetical protein CTLon_0521 CT273 Midlate I
euo Hypothetical protein CTLon_0702 CT446 –
sfhB Ribosomal large subunit pseudogenuridine synthase D CTLon_0027 CT658 –
Hypothetical protein CTLon_0607 CT355 –
Putative DNA methyltransferase CTLon_0733 CT477 –
hct2 Histone-like protein 2 CTLon_0297 CT046 Late
Hypothetical protein CTLon_0879 CT621 Midlate I
ndk Nucleoside diphosphate kinase CTLon_0757 CT500 Midlate I
pmpI Polymorphic outer membrane protein CTLon_0249 CT874 Midlate I
pgsA CDP-diacylglycerol–glycerol-3-phosphate 3-phosphatidyltransferase CTLon_0752 CT496 Midlate I
nqrA Na(+)-translocating NADH-quinone reductase subunit A CTLon_0002 CT634 Midlate I
Hypothetical protein CTLon_0635 CT382.1 –
A semi-quantitaive analysis of diﬀerentially expressed genes returned 84 protein coding genes, 38 overrepresented in EB and 46 more abundant in
RB. Sequence read numbers were counted as for each ORF including the 50-UTR if present and normalized by the total number of mRNA
transcripts for each library. Genes with a total number of at least 20 sequence reads and a 2-fold regulation were considered as diﬀerentially
expressed. A comparison to a microarray based gene expression study shows a high correlation of genes abundant in the late infection cycle phase to
EB and genes abundant in the midlate phases to RB.
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minus strand. Figure 3A shows a screenshot of the IGB
showing cDNA reads mapped on the plasmid, including
the annotated ORFs and regions of high transcriptional
activity. We found a highly abundant (>10000 reads)
small transcript pL2-sRNA1 of  80nt in length.
This sRNA is antisense to a predicted ORF coding for
the putative partitioning protein PCTB_7 (pL2-07a,
Figure 3A). Moreover, high transcriptional activity can
be detected antisense to the only predicted ORF on the
plus strand, pL2-02 (38), encoding virulence plasmid
integrase, pGP8-D. Northern blot experiments conﬁrmed
the expression of several small transcripts in 90–400nt size
range (Figure 3B, probes p4800, p4963, p5120) from this
plasmid region which lacks an ORF on the minus strand.
The largest RNA species has a size of  420nt and is
recognized by all probes. The second smallest RNA is
 220nt long, and was detected by the probes p4963 and
p5120. It has the same TSS as the longer RNA and could
be derived by 30 processing of the latter end. The smaller
RNA fragments, e.g. the 90nt fragment detected by p4963
are most likely processing products of larger fragments,
since no further TSS could be identiﬁed. TSS of the
plasmid encoded transcripts are indicated by arrows in
Figure 3A including the start coordinates.
We identiﬁed TSS for seven of the nine ORFs currently
annotated on the plasmid. The remaining two annotated
genes are expressed but lack a detectable TSS. The
sequencing data suggests that pL2-04 and -05 as well as
pL2-07a and -07 are transcribed from a common tran-
script, respectively. Interestingly, two distinct TSS could
be identiﬁed for the pL2-02 transcript whereas the
Figure 2. Validation of putative small RNAs by northern analysis. (A) Expression of eight out of twelve new candidate sRNAs could be conﬁrmed
by northern blotting whereas the length of the probed RNA corresponded to the calculated length from the sequencing data. The genomic location
of the sRNAs is shown in (B). ctrR1 is not a primary transcript but presumably processed from a larger transcript containing tRNA:Thr. ctrR2, 3,
5–7 are located intergenic and primary transcripts. Two sRNAs are transcribed from ctrR4 and the longer transcript overlaps the gene 403 on the
opposite strand. ctrR8 is located antisense to gene 807. ctrR0332 has previously been identiﬁed as ORF CTLon_0332, but represents two RNA
species processed from a larger transcript lacking an ORF. Details on the genomic location and the sequence of ctrR0332 are given in Supplementary
Figure S2. Two housekeeping RNAs (tmRNA and SRP RNA) and ihtA is the only so far reported chlamydial sRNA are shown in the right lanes.
Genomic locations, sequence read numbers and hybridization probes are given in Supplementary Table S2.
Nucleic AcidsResearch, 2010, Vol.38,No. 3 873Figure 3. Transcriptome of the cryptic plasmid. (A) Calculated sequence graphs for C. trachomatis cryptic plasmid. Graphs show the number of
sequence reads for every nucleotide of the plasmid up to the cut-oﬀ value of 10. Total RNA library reads are shown in grey and are overlaid by red
graphs for the TSS enriched libraries. Annotated ORFs are shown as black bars for the plus strand (upper) and minus strand (lower), respectively.
Note that total numbers for single transcripts are much higher than 10 but omitted for better visualization. TSS are indicated by horizontal arrows
marked with the start positions. Hybridization probe binding sites used for northern detection are marked by vertical arrowheads and the probe
name. (B) Northern analysis of C. trachomatis plasmid transcripts reveals a highly abundant small RNA pL2-sRNA1 of  100nt in length antisense
to pL2-07a. The region located antisense to the ORF pL2-02 encodes several transcripts in the range of  80–450nt. Probe binding sites are marked
by an arrow in (A). The names of the transcripts correspond to the ﬁrst nucleotide of the probe binding site.
Table 2. Putative targets of chlamydial non-coding RNAs
sRNA Start End Length RB read
number
EB read
number
Putative target mRNAs
ihtA 53029 53137 109 77 17 hctA, 317, 097, mgtE
ctrR1 53220 53363 144 136 227 819, 370, 505
ctrR2 126638 126536 103 1 2 492, tufA, nlpD, 753, 443, dnaA, 035, 730, secG
ctrR3 342947 342838 110 981 1761 248, 794, 190, pfrA, 218, 394, mip, rodA, 294, rbfA, def, ptsN_2, sctU
ctrR4 498126 497963 164 19 3 xerC, pknD, 626
ctrR5 586269 586341 73 8 3 dacC, gnd
ctrR6 725411 725268 144 75 19 824, rplL, 854, kdsA, 751, secG, ppa, 219
ctrR7 876694 876384 311 71 15 copB, 847, glnQ, 531, ssc2, 641, 623, 652, lpdA, ihfA, 597, tig, nusG, aroA
ctrR8 938403 938509 107 59 1 497, murE, eno, 080, 511, 013, 316, dnaQ
ctrR0332 416302 416641 340 1039 16960 333, atpK, 292, 586, gnd, 822, glgC
pL2-sRNA1 213 292 90 8332 1075 305, sucA, dnaG
Based on binding probability of the newly identiﬁed small non-coding RNAs putative binding partners were identiﬁed using the
TargetRNA algorithm. Hits were ﬁltered for binding of the sRNA to the translation start codon or the ribosome binding site. None of the
sRNAs is conserved in other bacteria than Chlamydiae. However some seed sequences are conserved among at least two other bacterial phyla.
Targets putatively bound by these conserved sequence elements are underlined. Putative target mRNAs are listed in order of their binding score
starting with the highest score.
874 Nucleic Acids Research, 2010,Vol. 38,No. 3transcript starting at  240nt is enriched in RB and the
transcript starting at  58nt is enriched in EB. This
suggests a transcriptional regulation by alternative
promoters depending on the developmental cycle phase.
DISCUSSION
The availability of genome sequences for many diﬀerent
bacterial species and their successive annotation has
initiated transcriptome analysis as a means to measure
gene activity. Using microarray technology, annotated
RNAs have been quantiﬁed very successfully in various
biological conditions. A shortcoming of these probe-
dependent approaches is, however, the indirect nature of
the RNA quantiﬁcation which allows only the detection
and quantiﬁcation of previously predicted RNAs with
only limited alterations. Moreover, the precise starts of
the 50 ends of most bacterial RNAs cannot be determined
by conventional transcriptome analyses but require inves-
tigation of individual genes by 50-RACE or RNA run-oﬀ
experiments. These limitations are especially relevant for
bacteria that cannot be genetically manipulated and
grown under laboratory conditions like obligate
intracellular bacteria. The gene structure and function of
this large group of bacteria including many important
human pathogens remains therefore poorly understood.
We have applied RNA-seq to deﬁne the TSS of
chlamydial genes at the single nucleotide level. Due to
the high resolution of the technology, we identiﬁed a
bona ﬁde non-coding RNA ctrR0332 as a species-
speciﬁc and most abundant RNA located in an annotated
ORF (CTLon_0332) in C. trachomatis. In addition,
numerous plasmid- and chromosomally encoded new
sRNA species could be identiﬁed by sequencing and
subsequently veriﬁed by northern blot analysis.
The deﬁnition of 356 TSS in a single sequencing run,
most of them to the single nucleotide level, demonstrates
the power of the method applied. The enzymatic depletion
of RNAs with 50 monophosphates was an essential step
for the resolution of the TSS. Noise caused by RNA
break-down products in many cases presumably would
have complicated the unequivocal identiﬁcation of TSS
in the sequences obtained from untreated RNA. Such a
precise mapping of TSS can now be used to characterize
the respective promoters and other gene control elements
by computational approaches.
Most of the discovered TSS clearly correlated with
annotated ORFs. Others are located antisense and
overlap unexpressed annotated ORFs like e.g.
CTLon_0175, CTLon_0184 and CTLon_0239. It has
been shown previously that these transcripts are expressed
and contain ORFs (39). However, numerous annotated
transcripts could not be detected, some of them
probably due to the limited depth of sequencing or the
low expression. On the other hand, we do not expect all
annotated 934 genes to have a deﬁned TSS, since
C. trachomatis genes are frequently organized in operons
such as the ten operons coding for a type three secretion
system (40). The operon structure can be analysed by
comparing total RNA and enriched cDNA libraries.
In enriched libraries a distinct TSS is present only for
the ﬁrst gene of an operon, whereas sequence reads are
obtained for genes located downstream in the non-
enriched libraries. Because of the polycistronic
organisation of transcripts, the number of TSS is
expected to be lower than the total ORF number.
Collectively, the number of 356 identiﬁed TSS is likely
to approach the real number of native transcript ends in
C. trachomatis.
Diﬀerential transcriptomics of EB and RB, the develop-
mentally diﬀerent stages of the chlamydial developmental
cycle, has been performed before from chromosomal genes
but not from plasmid-encoded genes (7,8). These studies
used infected cells at diﬀerent stages of the cycle as a
source to prepare RNA. Since the infection course is
asynchronous, later time points result in a mixture of
EB and RB. To overcome this challenge and to avoid
massive background of host RNAs, we generated libraries
from puriﬁed EB and RB providing proof of principle for
successful transcriptome analysis from puriﬁed chlamydial
particles.
We compared the relative abundances of RNAs from
the diﬀerent chlamydial developmental stages with the
published microarray expression data. Nicholson et al.
(8) classiﬁed clusters of temporal gene expression with
‘early’ (12h p.i.), ‘mid-late’ (18h p.i.), ‘late’ (24h p.i.)
and ‘very late’ (36h p.i.). EB are metabolically inactive,
and transcripts present in EB assure immediate translation
in early infection events. Such transcripts are produced in
the RB stage and stored in the EB, and therefore accumu-
late during the end of the infection cycle when the RB to
EB transition is completed. These genes correlate with
‘late’ and ‘very late’ gene expression from microarray
studies using RNA from time course experiments (Table 1).
Most of the transcripts overrepresented in EB are of
unknown function with the interesting exception of the
highly overrepresented RNA of an operon consisting of
the four genes CTLon_0833-0836. This transcript encodes
components of the T3SS such as the chaperone scc2, a
protein of unknown function, and the ATPase copB and
copD, all of which is consistent with the crucial role of the
T3SS early in infection (40). In the ‘mid-late’ stage, the RB
is the predominant form of Chlamydia. Of the 48 genes we
found to be up-regulated in RB, 27 were classiﬁed as ‘mid-
late’ and 5 as ‘late’ genes. Arguably, the use of diﬀerent
platforms and the temporal spectrum of RB-EB-
conversion limit a direct comparison of expression data,
i.e. obtained by microarrays versus direct transcriptome
sequencing of puriﬁed bacteria. Nevertheless, our semi-
quantitative analysis of relative RNA abundances
encoded by chromosomal genes from puriﬁed bacterial
stages by deep-sequencing correlated very well with the
previous microarray analyses of infected cells. This
indicates that the method is also suitable for relative quan-
titative measurements of RNA abundance.
Of all annotated ORFs, the most abundant transcript
was that of ORF CTLon_0332. Its transcript quantity is
comparable to the class of rRNAs or tRNAs, although it
was previously annotated as mRNA. Precise mapping of
the TSS and RNA length by northern blot revealed two
highly abundant non-coding RNAs. They are shorter than
Nucleic AcidsResearch, 2010, Vol.38,No. 3 875the annotated transcript, do not contain an ORF and are
present only in C. trachomatis and the closely related
mouse strain C. muridarium. It is noteworthy that
CTLon_0332 is about tenfold overrepresented in EB
which may indicate a role in the EB-RB transition.
The experimental prediction of 16 potential non-coding
RNAs in chromosomal IGRs and 25 located antisense
within annotated ORFs was another remarkable ﬁnding.
A total of 9 sRNAs was validated on northern blots,
which ﬁrmly demonstrates that C. trachomatis expresses
multiple sRNAs. Since chlamydial genomes are small and
highly optimized, intergenic regions are rare. The presence
of these sRNAs may indicate a strong evolutionary selec-
tion for their expression in C. trachomatis due to their
putative regulatory functions. The only previously
known chlamydial sRNA also identiﬁed here was IhtA
involved in translational regulation of histone-like
protein Hc-1 (25), supporting an important role of
sRNAs in regulating gene expression C. trachomatis.
Most bacteria express the conserved RNA-binding
protein Hfq, a pleiotropic regulator involved in the
sRNA-mediated control of mRNA stability or translation
(20). Chlamydia lack a Hfq homologue but the
translational control of Hc-1 expression by the trans-
encoded sRNA IhtA constitutes a riboregulatory event
that is typically facilited by Hfq in E. coli, the model bac-
terium of sRNA research. Whether a protein functionally
similar to Hfq controls sRNA function in C. trachomatis
remains to be shown. Clearly, the sRNAs identiﬁed here
provide a departure point to discover a general sRNA-
binding protein in Chlamydia by biochemical methods,
e.g. aptamer-facilitated aﬃnity puriﬁcation (41).
Our results demonstrate that the chlamydial cryptic
plasmid also expresses several sRNAs. Some were found
in antisense orientation to ORFs implying a role in the
regulation of plasmid-coded genes. One of these, pL2-
sRNA1 was among the most abundant RNAs identiﬁed
in C. trachomatis with more than 10000 reads. pL2-
sRNA1 codes for an RNA antisense to the gene for the
putative partitioning protein PCTB_7, a ParA homolog.
ParA proteins are membrane bound ATPases involved in
the partitioning of chromosomes and plasmids during rep-
lication. It is therefore likely that pL2-sRNA1 is involved
in the control of plasmid partitioning. The role of the
other plasmid-encoded sRNAs is less clear. They may
also be involved in the control of plasmid replication as
has been shown for many diﬀerent replicons (42). Yet
another possibility is the regulation of chromosomal
gene expression. Plasmid-free strains of C. trachomatis
down-regulate the activity of chromosomal glgA
encoding glycogen synthase leading to accumulation of
glycogen in the chlamydial inclusion and an attenuated
phenotype in mouse genital infection model (43).
Whereas the general and precise identiﬁcation of TSS
will help to better understand the genome organization,
the previously unknown highly abundant sRNAs
described here raise several questions on their role in
the physiology of C. trachomatis. Transcriptome
analyses by deep-sequencing of other chlamydial species
are on the way and will ultimately help to clarify whether
species-speciﬁc abundant sRNAs are common among
other members of the Chlamydiales.
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